日志 chi9iua
(English) Interview with Peter Pang: Where Biosimilar CMC Risk Really Sits Today
对不起，此内容只适用于English。 For the sake of viewer convenience, […]
(English) Interview: Biosimilars, a market reaching an inflection point — a conversation with Frederic Bouvier
对不起，此内容只适用于English。 For the sake of viewer convenience, […]